BeiGene, Ltd. (BGNE) financial statements (2021 and earlier)

Company profile

Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN)
GRAND CAYMAN, KY1-1108
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,6519831,781838368
Cash and cash equivalents1,38261871324088
Short-term investments3,2693651,069598281
Restricted cash and investments0015  
Receivables76735329 
Inventory, net of allowances, customer advances and progress billings89291611 
Inventory89291611 
Prepaid expense431920  
Other undisclosed current assets1017059366
Total current assets:4,9611,1731,944913374
Noncurrent Assets
Operating lease, right-of-use asset91 
Property, plant and equipment3582421576326
Intangible assets, net (including goodwill)5677 
Goodwill  00 
Intangible assets, net (excluding goodwill)5677 
Restricted cash and investments8213  
Deferred income tax assets66 
Other noncurrent assets1136854435
Other undisclosed noncurrent assets 12075201
Total noncurrent assets:64044030613331
TOTAL ASSETS:5,6011,6122,2501,046406
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:5982991009617
Accounts payable232122 7012
Accrued liabilities346164   
Employee-related liabilities  36174
Taxes payable2013 91
Other undisclosed accounts payable and accrued liabilities  65  
Debt335 99 
Deferred revenue and credits12 
Other undisclosed current liabilities142111373318
Total current liabilities:1,07531024615035
Noncurrent Liabilities
Long-term debt and lease obligation2138341917
Long-term debt, excluding current maturities1848341917
Operating lease, liability29 
Liabilities, other than long-term debt682041882031
Deferred revenue and credits25 
Deferred income tax liabilities11 
Due to related parties 157149146 
Other liabilities574739321
Other undisclosed noncurrent liabilities3753621  
Total noncurrent liabilities:65632425021218
Total liabilities:1,73263449636253
Stockholders' equity
Stockholders' equity attributable to parent3,8699621,739670353
Common stock00000
Additional paid in capital7,4152,9262,7451,001591
Accumulated other comprehensive income (loss)7(8)2(0)(1)
Accumulated deficit(3,553)(1,956)(1,007)(331)(237)
Stockholders' equity attributable to noncontrolling interest 161414 
Total stockholders' equity:3,8699781,754684353
TOTAL LIABILITIES AND EQUITY:5,6011,6122,2501,046406

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues3094281982381
Revenue, net236 
Cost of revenue
(Cost of Goods and Services Sold)
(71)(71)(29)(5) 
Gross profit:2383571702331
Operating expenses(1,896)(1,317)(875)(332)(118)
Operating loss:(1,658)(960)(706)(98)(117)
Nonoperating income
(Other Nonoperating income)
3772110
Interest and debt expense(18)    
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes20914(4) 
Loss from continuing operations before equity method investments, income taxes:(1,618)(944)(690)(91)(117)
Income from equity method investments12    
Other undisclosed loss from continuing operations before income taxes    (3)
Loss from continuing operations before income taxes:(1,606)(944)(690)(91)(119)
Income tax expense (benefit)18(7)16(2)(0)
Loss before gain (loss) on sale of properties:(1,589)(951)(674)(93)(119)
Other undisclosed net loss(12)    
Net loss:(1,601)(951)(674)(93)(119)
Net income attributable to noncontrolling interest4200 
Net loss available to common stockholders, diluted:(1,597)(949)(674)(93)(119)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(1,601)(951)(674)(93)(119)
Other comprehensive income (loss)15(10)   
Other undisclosed comprehensive income (loss) (0)211
Comprehensive loss:(1,585)(960)(672)(93)(118)
Comprehensive income, net of tax, attributable to noncontrolling interest3200 
Comprehensive loss, net of tax, attributable to parent:(1,582)(958)(672)(93)(118)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: